Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?
Clinical trial NCT04606563 · TERMINATED
Trial details
- NCT number
- NCT04606563
- Sponsor
- University of British Columbia
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-09
- Primary completion
- 2022-04-22
- Enrollment
- 341
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.